News Desk, Amar Ujala, New Delhi
Updated Thu, 19 Nov 2020 07:59 AM IST
Listen to the news
India in third place
According to a report by the American magazine Wall Street Journal, India ranks third in terms of buying vaccine doses. The US and the European Union rank first and second respectively. The report is based on Duke University’s Launch and Scale Speedometer Initiative, which studies factors that hamper health initiatives in low-income countries. According to the ‘Launch and Scale Speedometer Initiative’, India ranks third in terms of ‘Kovid-19 Vaccine Advance Market Commitments’ after the US and the European Union.
India has confirmed to buy more than 1.5 billion doses, which is more than 1.2 billion doses of EU and 1 billion doses of US. But the US and the European Union are ahead due to their potential dosage purchases. The US has signed up for over 1.5 billion possible dose purchases. At the same time, the European Union has signed for more than 76 million possible dose purchases.
Also Read: Coronavirus Vaccine: Government Expects On These Five Corona Vaccines, Testing Continues
America made 2.6 billion dose books
The US has signed on for about 2.6 billion doses with a potential 1.5 billion dose purchase and 1 billion dose booking. This shows that the world’s most powerful country can vaccinate its entire population more than once.
Vaccines will be preferred in India
India is already prioritizing identifying people who will be vaccinated first. The ‘National Expert Group’ on Vaccine Administration is working on a time-bound process to vaccinate the maximum number of people after a fully effective vaccine is introduced.
8 billion dose book in the world
Researchers at Duke University’s Launch and Scale Speedometer Initiative say that the number suggests that more than 8 billion doses of the Corona vaccine are currently booked, while no clear results have been revealed about the vaccine’s efficacy. US drug maker Pfizer and its German partner BioNotech SE have said that their vaccine vaccine has been found to be 95 percent effective.